CAT
Caterpillar Inc.
CAT has the edge over JBI overall, supported by lower modeled downside and stronger modeled upside.
JBI
Janus International Group, Inc.
JBI trails on the overall score without a compensating advantage in the available component scores.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
JBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Under pressure |
JBI's revenue, profitability and cash flow are currently stable, but its balance sheet is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over JBI in the historical PE scenario, which offers more potential upside but is not a forecast.
JBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $0.24 | -94% |
| Fair | 15x | $0.31 | -92% |
| Expensive | 24x | $0.48 | -87% |
| Current | 188x | $3.75 | — |
Historical ranges are pointers, not guarantees.
JBI's PE is in its expensive range at 188x.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
JBI Forward outlook
There aren't enough analyst estimates for JBI to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over JBI on earnings, with more consistent year-over-year improvement.
JBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.02 | -94% |
| Q2 2026 | $0.23 | -28% |
| Q1 2026 | $0.30 | -17% |
| Q4 2025 | $0.38 | -22% |
| Q3 2025 | $0.35 | -51% |
| Q2 2025 | $0.32 | -64% |
| Q1 2025 | $0.36 | -62% |
| Q4 2024 | $0.49 | -47% |
JBI's earnings per share have fallen from their peak: $0.02 over the past year, against $0.95 in early 2024.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over JBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over JBI on profitability, with a higher operating margin.
JBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $213.1M | -2.8% |
| Q2 2026 | $233.5M | +2.4% |
| Q1 2026 | $222.7M | +5.8% |
| Q4 2025 | $226.3M | -1.9% |
| Q3 2025 | $219.3M | -4.7% |
| Q2 2025 | $228.1M | -8.2% |
| Q1 2025 | $210.5M | -17% |
| Q4 2024 | $230.8M | -13% |
JBI's revenue fell from its 2023 peak and has held roughly level since: $213M last quarter, down 2.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.6% | -16 points |
| Q2 2026 | 8.8% | -7 points |
| Q1 2026 | 5.9% | -6.1 points |
| Q4 2025 | 9.2% | +3.6 points |
| Q3 2025 | 13% | +1.8 points |
| Q2 2025 | 16% | -5 points |
| Q1 2025 | 12% | -9.8 points |
| Q4 2024 | 5.5% | -19 points |
JBI's operating margin was −2.6% last quarter, down 16 points from the same quarter a year ago, near the bottom of its range since 2020.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over JBI on cash flow, with more consistent year-over-year improvement.
JBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $31.5M | +280% |
| Q2 2026 | $21.6M | -52% |
| Q1 2026 | $33.4M | -20% |
| Q4 2025 | $19.2M | -58% |
| Q3 2025 | $8.3M | -79% |
| Q2 2025 | $44.6M | +76% |
| Q1 2025 | $41.9M | +75% |
| Q4 2024 | $45.3M | -28% |
JBI's free cash flow has been positive every quarter for six years: $106M over the past year, down 25% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
JBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -2.1M shares |
| 1 year | -3.6% | -5M shares |
| 3 years | -8.5% | -12.6M shares |
| 5 years | +65% | +52.8M shares |
| Available history | -2.8% | -3.9M shares |
JBI has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25.1M |
| Q2 2026 | $1.9M |
| Q1 2026 | $15.5M |
| Q4 2025 | — |
| Q3 2025 | $900,000 |
| Q2 2025 | $10M |
| Q1 2025 | $5M |
| Q4 2024 | $8.6M |
JBI spent $43M buying back its own shares over the past year, up 73% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over JBI on leverage, with a lower net debt burden relative to earnings.
JBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.3x | Moderate |
JBI's net debt is about 3.7 years of its operating earnings (EBITDA), up from 2.5 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
JBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.4 | Neutral |
| Stochastic | 27.9 | Neutral |
JBI's weekly RSI is 31 (neutral) and its Stochastic is 28 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over JBI on valuation relative to its sector.
JBI PE vs Industrials Sector
| Metric | JBI | Sector median | Relative |
|---|---|---|---|
| PE | 188x | 24x | 679% above |
| PE % | 100 | 58 | 42 pts above |
JBI is trading at 188x earnings, a 679% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over JBI on trend strength, trading above more of its moving averages.
JBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.28 | 12% below |
| 20 week MA | $4.76 | 21% below |
| 50 week MA | $5.48 | 32% below |
| 100 week MA | $6.91 | 46% below |
| 200 week MA | $9.12 | 59% below |
JBI is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over JBI on returns for 2026, with the stronger performance.
JBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2019 | $9.77 | $9.83 | +0.6% |
| 2020 | $9.83 | $11.1 | +13% |
| 2021 | $11.1 | $12.4 | +11% |
| 2022 | $12.4 | $9.35 | -24% |
| 2023 | $9.35 | $13.1 | +40% |
| 2024 | $13.1 | $7.36 | -44% |
| 2025 | $7.36 | $6.77 | -8% |
| 2026 YTD | $6.77 | $3.75 | -45% |
JBI has finished lower in three of the last six years. It's down 45% so far in 2026.